A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
This research study is designed to see how safe a new medicine called PTC923 is for people living with Phenylketonuria, or PKU, over a long period. PKU is a condition where the body can't properly process a substance called phenylalanine, found in protein. People with PKU usually need a very strict diet. The study also aims to understand if taking PTC923 allows participants to eat a wider variety of foods, specifically looking at how their intake of phenylalanine and protein might change from what they usually eat. It includes people who have been in previous studies and those who haven't, checking both those with controlled and uncontrolled phenylalanine levels.
A colpo d'occhio
Di cosa tratta questo studio?
This study is investigating a new medication called PTC923 for people with a genetic condition called Phenylketonuria, or PKU. PKU means your body has trouble breaking down a substance called phenylalanine, which is found in protein-rich foods. If phenylalanine builds up, it can cause health problems, so people with PKU usually follow a very strict diet to control their levels.
The main goal of this study is to carefully watch the long-term safety of PTC923. Researchers want to make sure the medicine is well-tolerated and doesn't cause unexpected problems when taken over a longer time. They also want to see if the medicine helps people manage their PKU better, for example, by allowing them to eat a bit more protein or a wider range of foods than their usual strict diet permits. They'll measure how people's dietary phenylalanine and protein intake might change.
Participants in this study might be people who have already tried PTC923 in a previous study (these are called 'feeder participants'). It also includes people new to the medication, categorised based on their current phenylalanine levels in the blood – either controlled (low levels) or uncontrolled (higher levels). This helps researchers understand how PTC923 works in different situations.
Punti chiave
- This study is testing a new medicine called PTC923 for Phenylketonuria (PKU).
- Its main aim is to understand the long-term safety of PTC923.
- Researchers will also see if the medicine helps people with PKU adjust their diet.
- Both new participants and those from previous studies can join.
- You'll have regular check-ups to monitor your health and diet.
Chi può essere idoneo?
To join this study, you generally need to have a confirmed diagnosis of PKU and have had high phenylalanine levels in your blood in the past. If you are a woman who could become pregnant, you'll need to have a negative pregnancy test and agree to use effective birth control throughout the study and for 90 days after your last dose. Men who are sexually active with women who could become pregnant also need to use barrier birth control during this period and avoid donating sperm.
You should be willing to stick to your current diet unless the study doctors ask you to make changes. It's important that you can take medicines by mouth and are not pregnant or breastfeeding, or planning to become pregnant. You also can't have serious uncontrolled mental health conditions or certain kidney problems.
There are a few other reasons you might not be able to join, such as needing other medicines that could interfere with the study drug, like methotrexate, or if the researchers believe there's any other reason it wouldn't be safe or appropriate for you.
Questo studio potrebbe fare al caso tuo?
Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.
- Do I have a confirmed diagnosis of PKU?
- Can I take medicines by mouth without problems?
- If I am a woman, am I able to use effective birth control, and am I not pregnant or breastfeeding?
- Do I have any serious kidney problems?
- Do I need any other medicines that could interfere with the study drug?
Cosa comporta la partecipazione?
If you join the study, you'll be taking the study medicine, PTC923, as instructed by the study team. You'll have regular visits to the clinic so doctors can monitor your health, check your blood phenylalanine levels, and see how your diet might be changing. They will also look for any side effects from the medicine.
You will continue to follow your usual PKU diet unless the study doctor advises you to make adjustments. The study is designed to look at long-term safety, so it will involve regular check-ups over an extended period. The exact number of visits and the total duration will be explained in detail by the study team.
Rischi e benefici potenziali
Luoghi (46)
- Ospedale Pediatrico del ColoradoCodice postale verificatoAurora, Stati Uniti
- UF College of Medicine, Department of Pediatrics Division of Genetics and MetabolismCodice postale verificatoGainesville, Stati Uniti
- Indiana University School of Medicine Department of Medical and Molecular GeneticsCodice postale verificatoIndianapolis, Stati Uniti
- Ospedale Pediatrico di BostonCodice postale verificatoBoston, Stati Uniti
- Icahn School of Medicine at Mount Sinai (ISMMS)Codice postale verificatoNew York, Stati Uniti
- UPMC Children's Hospital of PittsburghCodice postale verificatoPittsburgh, United States
- University of UtahCodice postale verificatoSalt Lake City, United States
- The Queensland Children's HospitalCodice postale verificatoSouth Brisbane, Australia
- Westmead HospitalCodice postale verificatoWestmead, Australia
- PARC Clinical ResearchCodice postale verificatoAdelaide, Australia
- Royal Children's HospitalCodice postale verificatoParkville, Australia
- Hospital de clinicas de Porto AlegreCodice postale verificatoPorto Alegre, Brazil
Domande comuni
What is Phenylketonuria (PKU)?
PKU is a genetic condition where your body can't properly break down a substance called phenylalanine, which is found in protein. This means people with PKU need a special diet.
What is the new medicine, PTC923?
PTC923 is a new medicine being tested to see if it can help people with PKU manage their condition and potentially allow for a less restrictive diet.
Will I have to change my diet on this study?
You'll be asked to continue your current diet unless the study doctors specifically tell you to make changes. The study will monitor if your diet naturally changes over time.
Qual è l'obiettivo principale di questo studio?
The main goal is to check how safe PTC923 is for people with PKU when taken over a long time, and to see if it affects their diet.
Per quanto tempo sarò nello studio?
This is a long-term study, so your participation will involve regular check-ups over an extended period. The exact duration will be discussed with you.
Come saperne di più
Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.
Discussione
Discussione della comunità
Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.